Janux Therapeutics, Inc.JANXNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
28.19%
↑ 192% above average
Average (22q)
-30.58%
Historical baseline
Range
High:59.63%
Low:-370.87%
Volatility
-1407.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 28.19% |
| Q2 2025 | -44.03% |
| Q1 2025 | -16.28% |
| Q4 2024 | 27.95% |
| Q3 2024 | -370.87% |
| Q2 2024 | 59.63% |
| Q1 2024 | -25.53% |
| Q4 2023 | -1.64% |
| Q3 2023 | 33.93% |
| Q2 2023 | -0.28% |
| Q1 2023 | -8.68% |
| Q4 2022 | 3.78% |
| Q3 2022 | 1.14% |
| Q2 2022 | -25.94% |
| Q1 2022 | 0.04% |
| Q4 2021 | -24.61% |
| Q3 2021 | -73.48% |
| Q2 2021 | -171.72% |
| Q1 2021 | -38.01% |
| Q4 2020 | -31.77% |
| Q3 2020 | 48.94% |
| Q2 2020 | -74.10% |
| Q1 2020 | 0.00% |